Infliximab for uveitis of Behcet's syndrome: a trend for earlier initiation


Guzelant G., Ucar D., Esatoglu S. N. , Hatemi G., Ozyazgan Y., Yurdakul S., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.35, 2017 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 35 Konu: 6
  • Basım Tarihi: 2017
  • Dergi Adı: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Özet

Objective. The prognosis of uveitis in Behcet's syndrome (BS) has improved over decades. Whether this is related to the use of more aggressive management strategies is not known.